Matinas Biopharma Holdings Inc. (MTNB) Rose 21.18% or 0.15 To Price $0.89 On Tuesday


Matinas Biopharma Holdings Inc. (MTNB) rose 21.18% or 0.15 to $0.89. It is near 3.82 million shares traded, which is 88.52% compare to the average total volume 4.32 million. The market cap of MTNB is $83.88 million. The year to date change is -19.84%. The 52 week price range is from $0.32 to $1.6. Price of MTNB have changed 2.01% during last week. It have changed 17.89% over last month, 90.44% over last 3 months, 17.95% over last 6 months and -34.85% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for MTNB is 0.66. It is -25.84% below current price. The 200-day Moving Averages for MTNB is 0.67. It is -24.72% below current price. The 52-week High is 1.6. It is 79.78% from the current price. The 52-week Low is 0.32. It is -64.04% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of MTNB is 0.67 on 2018-10-15. Short % to float is 2.71%. There are some statistics of MTNB. It is has market cap $83.88 million. The share outstanding is 94.64 million. The average volume is 4.32 million. The percent of top 15 Institution holding is 17.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of MTNB is -322.17%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of MTNB is -89.57%.


Tags:

Share this post